- Report
- November 2025
- 150 Pages
Global
From €3414EUR$3,750USD£2,929GBP
- Report
- November 2025
- 150 Pages
Global
From €3414EUR$3,750USD£2,929GBP
- Report
- August 2026
- 180 Pages
Global
From €4325EUR$4,750USD£3,710GBP
- Report
- August 2026
- 115 Pages
Global
From €4325EUR$4,750USD£3,710GBP
- Report
- July 2026
- 115 Pages
Global
From €4325EUR$4,750USD£3,710GBP
- Report
- July 2026
- 180 Pages
Global
From €4325EUR$4,750USD£3,710GBP
- Report
- July 2026
- 110 Pages
Global
From €4325EUR$4,750USD£3,710GBP
- Report
- June 2026
- 110 Pages
Global
From €4325EUR$4,750USD£3,710GBP
- Report
- June 2026
- 150 Pages
Global
From €4325EUR$4,750USD£3,710GBP
- Report
- January 2026
- 200 Pages
Global
From €4548EUR$4,995USD£3,901GBP
- Report
- October 2025
- 160 Pages
Global
From €2877EUR$3,160USD£2,468GBP
€3596EUR$3,950USD£3,085GBP
- Report
- August 2026
- 160 Pages
Global
From €3023EUR$3,320USD£2,593GBP
€3779EUR$4,150USD£3,241GBP
- Report
- August 2026
- 160 Pages
Global
From €3023EUR$3,320USD£2,593GBP
€3779EUR$4,150USD£3,241GBP
- Report
- August 2026
- 160 Pages
Global
From €3023EUR$3,320USD£2,593GBP
€3779EUR$4,150USD£3,241GBP
- Report
- November 2025
- 94 Pages
Global
From €3500EUR$4,118USD£3,108GBP
- Report
- April 2026
- 128 Pages
Global
From €3500EUR$4,118USD£3,108GBP
- Report
- February 2026
- 114 Pages
Global
From €3500EUR$4,118USD£3,108GBP
- Report
- January 2026
- 150 Pages
Global
From €4416EUR$4,850USD£3,788GBP
- Report
- November 2025
- 150 Pages
Global
From €4416EUR$4,850USD£3,788GBP
- Report
- December 2025
Global
From €6829EUR$7,500USD£5,858GBP

The Blood Cell market is a subset of the biotechnology industry that focuses on the development of products and services related to the study and manipulation of blood cells. This includes the production of blood cell-based therapeutics, such as monoclonal antibodies, as well as the development of diagnostic tests and treatments for blood-related diseases. Blood cell research is also used to develop treatments for cancer, autoimmune diseases, and other conditions.
The Blood Cell market is a rapidly growing sector of the biotechnology industry, with new products and services being developed to meet the needs of patients and healthcare providers. Companies in this market are focused on developing innovative technologies and treatments to improve patient outcomes and reduce healthcare costs.
Some of the companies in the Blood Cell market include AbbVie, Amgen, AstraZeneca, Biogen, Celgene, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Regeneron Pharmaceuticals. Show Less Read more